Phentermine (brand names Adipex-P, Lomaira) is the most prescribed weight loss drug in America by volume — and has been for decades. It's cheap, it's widely available, and it works through a completely different mechanism than GLP-1 medications. Comparing them reveals how fundamentally the weight-loss pharmacology landscape has changed.
Mechanism: Stimulant vs. Hormone Mimic
Phentermine is an amphetamine analog. It works by increasing norepinephrine release in the brain, which suppresses appetite and increases energy expenditure — essentially, it makes you less hungry and more alert through sympathetic nervous system activation. It's the same class of mechanism as many ADHD medications.
GLP-1 agonists work by mimicking a gut hormone. They slow gastric emptying, increase insulin secretion, and act on brain centers involved in appetite regulation and reward. They don't stimulate the nervous system — they modulate the hormonal pathways that control hunger.
Efficacy Comparison
| Factor | Phentermine | Semaglutide 2.4mg | Tirzepatide 15mg |
|---|---|---|---|
| Avg weight loss | ~5–7% | ~15% | ~22.5% |
| FDA duration limit | 12 weeks | No limit (chronic) | No limit (chronic) |
| Monthly cost | $10–$30 (generic) | $99–$1,300 | $133–$1,059 |
| CV risk data | May increase HR/BP | 20% MACE reduction (SELECT) | Pending (SURPASS-CVOT) |
| Abuse potential | Schedule IV controlled | Not controlled | Not controlled |
GLP-1 medications produce roughly 2–4 times more weight loss than phentermine, can be used indefinitely, and have demonstrated cardiovascular benefits rather than risks. Phentermine costs a fraction of the price but is FDA-approved only for short-term use and carries cardiovascular concerns that GLP-1s do not.
Phentermine remains relevant for patients who need affordable short-term appetite suppression, can't access or afford GLP-1 medications, don't have cardiovascular risk factors that contraindicate stimulants, or want a bridge treatment while waiting for GLP-1 insurance coverage. It's not obsolete — it's a different tool for different circumstances. But for patients seeking significant, sustained weight loss with long-term metabolic benefits, GLP-1 medications are in a different league.
Injectable semaglutide only. Physician-led, fast onboarding, custom metabolic report. HSA/FSA accepted.
Sema $99/mo, tirz $133/mo. LegitScript, 503A+503B pharmacies. Free consult, free shipping, no membership. Code x7X72r saves $25.
Injectable, oral tirzepatide, microdose. LegitScript. Flat pricing at every dose — no jumps. Commitment plans from $49/mo.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. All medications require evaluation by a licensed healthcare provider. Compounded medications are not FDA-approved. Individual results vary.